Unknown

Dataset Information

0

Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.


ABSTRACT: Glycogen storage disease type II (Pompe disease; MIM 232300) stems from the deficiency of acid alpha-glucosidase (GAA; acid maltase; EC 3.2.1.20), which primarily involves cardiac and skeletal muscles. An adeno-associated virus 2/8 (AAV2/8) vector containing the muscle creatine kinase (MCK) (CK1) reduced glycogen content by approximately 50% in the heart and quadriceps in GAA-knockout (GAA-KO) mice; furthermore, an AAV2/8 vector containing the hybrid alpha-myosin heavy chain enhancer-/MCK enhancer-promoter (MHCK7) cassette reduced glycogen content by >95% in heart and >75% in the diaphragm and quadriceps. Transduction with an AAV2/8 vector was higher in the quadriceps than in the gastrocnemius. An AAV2/9 vector containing the MHCK7 cassette corrected GAA deficiency in the distal hindlimb, and glycogen accumulations were substantially cleared by human GAA (hGAA) expression therein; however, the analogous AAV2/7 vector achieved much lower efficacy. Administration of the MHCK7-containing vectors significantly increased striated muscle function as assessed by increased Rotarod times at 18 weeks after injection, whereas the CK1-containing vector did not increase Rotarod performance. Importantly, type IIb myofibers in the extensor digitalis longus (EDL) were transduced, thereby correcting a myofiber type that is unresponsive to enzyme replacement therapy. In summary, AAV8 and AAV9-pseudotyped vectors containing the MHCK7 regulatory cassette achieved enhanced efficacy in Pompe disease mice.

SUBMITTER: Sun B 

PROVIDER: S-EPMC2670546 | biostudies-literature | 2008 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.

Sun Baodong B   Young Sarah P SP   Li Ping P   Di Chunhui C   Brown Talmage T   Salva Maja Z MZ   Li Songtao S   Bird Andrew A   Yan Zhen Z   Auten Richard R   Hauschka Stephen D SD   Koeberl Dwight D DD  

Molecular therapy : the journal of the American Society of Gene Therapy 20080617 8


Glycogen storage disease type II (Pompe disease; MIM 232300) stems from the deficiency of acid alpha-glucosidase (GAA; acid maltase; EC 3.2.1.20), which primarily involves cardiac and skeletal muscles. An adeno-associated virus 2/8 (AAV2/8) vector containing the muscle creatine kinase (MCK) (CK1) reduced glycogen content by approximately 50% in the heart and quadriceps in GAA-knockout (GAA-KO) mice; furthermore, an AAV2/8 vector containing the hybrid alpha-myosin heavy chain enhancer-/MCK enhanc  ...[more]

Similar Datasets

| S-EPMC1365046 | biostudies-literature
| S-EPMC8106912 | biostudies-literature
| S-SCDT-EMM-2021-14434 | biostudies-other
| S-EPMC3293608 | biostudies-other
| S-EPMC9142766 | biostudies-literature
| S-EPMC2988075 | biostudies-literature
| S-EPMC9573825 | biostudies-literature
| S-EPMC2652365 | biostudies-literature
| S-EPMC6606965 | biostudies-literature
| S-EPMC8573602 | biostudies-literature